Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. - Creed, T. J.; Norman, M. R.; Probert, C. S. J.; Harvey, R. F.; Shaw, I. S.; Smithson, J.; Anderson, J.; Moorghen, M.; Gupta, J.; Shepherd, N. A.; Dayan, C. M.; Hearing, S. D. (Alimentary Pharmacology & Therapeutics, 2003)